Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 168 articles: HTML format

Single Articles

March 2023
1. FREUND MR, Emile SH, Horesh N, Garoufalia Z, et al
   The importance of surgical resection in the management of rectal sarcoma: A national cancer database analysis of 133 cases.
   Eur J Surg Oncol. 2023;49:647-654.
   PubMed     Abstract available
   
   
   
2. PERRIN ML, Bardet SM, Yardin C, Durand Fontanier S, et al
   Effect of 5-Fluoro-Uracile + Oxaliplatin chemotherapy on the histological response of PEritoneal and hePatIc corectal metasTases in a mOuse model: PEPITO experimental study.
   Eur J Surg Oncol. 2023;49:619-625.
   PubMed     Abstract available
   
   
   
3. DIAZ VICO T, Granero Castro P, Alcover Navarro L, Suarez Sanchez A, et al
   Two stage hepatectomy (TSH) versus ALPPS for initially unresectable colorectal liver metastases: A systematic review and meta-analysis.
   Eur J Surg Oncol. 2023;49:550-559.
   PubMed     Abstract available
   
   
   
4. KAZI M, Desouza A, Saklani A
   What are the preoperative predictors of a futile pelvic exenteration in rectal cancers?
   Eur J Surg Oncol. 2023;49:633-640.
   PubMed     Abstract available
   
   
   
5. MARI G, Santambrogio G, Crippa J, Cirocchi R, et al
   5 year oncological outcomes of the HIGHLOW randomized clinical trial.
   Eur J Surg Oncol. 2023;49:641-646.
   PubMed     Abstract available
   
   
   February 2023
6. LEE D, Wang A, Augustin B, Buajitti E, et al
   Socioeconomic status influences participation in cancer prehabilitation and preparation for surgical recovery: A pooled retrospective analysis using a validated area-level socioeconomic status metric.
   Eur J Surg Oncol. 2023;49:512-520.
   PubMed     Abstract available
   
   
   
7. CABEZON-GUTIERREZ L, Custodio-Cabello S, Palka-Kotlowska M, Diaz-Perez D, et al
   Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer: The future new standard approach?
   Eur J Surg Oncol. 2023;49:323-328.
   PubMed     Abstract available
   
   
   
8. EMILE SH, Silva-Alvarenga E, Horesh N, Freund MR, et al
   Concordance between clinical and pathologic assessment of T and N stages of rectal adenocarcinoma patients who underwent surgery without neoadjuvant therapy: A National Cancer Database analysis.
   Eur J Surg Oncol. 2023;49:426-432.
   PubMed     Abstract available
   
   
   
9. SHAO S, Zhao Y, Lu Q, Liu L, et al
   Artificial intelligence assists surgeons' decision-making of temporary ileostomy in patients with rectal cancer who have received anterior resection.
   Eur J Surg Oncol. 2023;49:433-439.
   PubMed     Abstract available
   
   
   
10. TINGUELY P, Laurell G, Enander A, Engstrand J, et al
    Ablation versus resection for resectable colorectal liver metastases - Health care related cost and survival analyses from a quasi-randomised study.
    Eur J Surg Oncol. 2023;49:416-425.
    PubMed     Abstract available
    
    
    
11. MATSUO K, Vallejo A, Barakzai SK, Nusbaum DJ, et al
    Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy.
    Eur J Surg Oncol. 2023;49:461-467.
    PubMed     Abstract available
    
    
    January 2023
12. PAVEL MC, Casanova R, Estalella L, Memba R, et al
    Impact of neoadjuvant chemotherapy on post-hepatectomy regeneration for patients with colorectal cancer liver metastasis - Systematic review and meta-analysis.
    Eur J Surg Oncol. 2023 Jan 3:S0748-7983(22)01363.
    PubMed     Abstract available
    
    
    
13. BOUBADDI M, Fleming C, Vendrely V, Frulio N, et al
    Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation.
    Eur J Surg Oncol. 2023;49:237-243.
    PubMed     Abstract available
    
    
    
14. YANG R, Su YD, Ma R, Li Y, et al
    Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate.
    Eur J Surg Oncol. 2023;49:173-178.
    PubMed     Abstract available
    
    
    
15. BOHLOK A, Inchiostro L, Lucidi V, Vankerckhove S, et al
    Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases.
    Eur J Surg Oncol. 2023;49:217-224.
    PubMed     Abstract available
    
    
    
16. CARVALHO F, Qiu S, Panagi V, Hardy K, et al
    Total Pelvic Exenteration surgery - Considerations for healthcare professionals.
    Eur J Surg Oncol. 2023;49:225-236.
    PubMed     Abstract available
    
    
    
17. KIM JC, Lee JL, Kim CW, Kim JR, et al
    Technical, functional, and oncological validity of robot-assisted total-intersphincteric resection (T-ISR) for lower rectal cancer.
    Eur J Surg Oncol. 2023;49:188-195.
    PubMed     Abstract available
    
    
    
18. KAZI M, Jajoo B, Rohila J, Dohale S, et al
    Functional outcomes after robotic or laparoscopic intersphincteric resection - An inverse probability weighting analysis.
    Eur J Surg Oncol. 2023;49:196-201.
    PubMed     Abstract available
    
    
    December 2022
19. ZAMARAY B, Veld JV, Burghgraef TA, Brohet R, et al
    Risk factors for a permanent stoma after resection of left-sided obstructive colon cancer - A prediction model.
    Eur J Surg Oncol. 2022 Dec 23:S0748-7983(22)01354.
    PubMed     Abstract available
    
    
    
20. WANG X, Zheng Z, Xie Z, Yu Q, et al
    Development and validation of artificial intelligence models for preoperative prediction of inferior mesenteric artery lymph nodes metastasis in left colon and rectal cancer.
    Eur J Surg Oncol. 2022;48:2475-2486.
    PubMed     Abstract available
    
    
    
21. PIENIOWSKI EHA, Nordenvall C, Johar A, Palmer G, et al
    Defunctioning stoma in rectal cancer surgery - A risk factor for Low Anterior Resection Syndrome?
    Eur J Surg Oncol. 2022;48:2518-2524.
    PubMed     Abstract available
    
    
    
22. VILLARD C, Abdelrafee A, Habib M, Ndegwa N, et al
    Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
    Eur J Surg Oncol. 2022;48:2432-2439.
    PubMed     Abstract available
    
    
    
23. SVANSTROM ROJVALL A, Buchli C, Saaf M, Magnusson P, et al
    Impact of radiotherapy on bone health in women with rectal cancer - A prospective cohort study.
    Eur J Surg Oncol. 2022;48:2509-2517.
    PubMed     Abstract available
    
    
    
24. AIBA T, Uehara K, Tsuyuki Y, Ogura A, et al
    Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
    Eur J Surg Oncol. 2022;48:2502-2508.
    PubMed     Abstract available
    
    
    
25. HOEK VT, Buettner S, Sparreboom CL, Detering R, et al
    A preoperative prediction model for anastomotic leakage after rectal cancer resection based on 13.175 patients.
    Eur J Surg Oncol. 2022;48:2495-2501.
    PubMed     Abstract available
    
    
    
26. NAGANO H, Kajitani R, Ohno R, Munechika T, et al
    Comparison of oncological outcomes between low anterior resection and abdominoperineal resection for rectal cancer: A retrospective cohort study using a multicenter database in Japan.
    Eur J Surg Oncol. 2022;48:2467-2474.
    PubMed     Abstract available
    
    
    
27. WEILERT H, Sadeghi D, Lipp M, Oldhafer KJ, et al
    Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
    Eur J Surg Oncol. 2022;48:2487-2494.
    PubMed     Abstract available
    
    
    November 2022
28. VAN DER HULST HC, van der Bol JM, Bastiaannet E, Portielje JEA, et al
    Surgical and non-surgical complications after colorectal cancer surgery in older patients; time-trends and age-specific differences.
    Eur J Surg Oncol. 2022 Nov 24:S0748-7983(22)00823.
    PubMed     Abstract available
    
    
    
29. TAFFURELLI G, Montroni I, Ghignone F, Zattoni D, et al
    Frailty assessment can predict textbook outcomes in senior adults after minimally invasive colorectal cancer surgery.
    Eur J Surg Oncol. 2022 Nov 8. pii: S0748-7983(22)00734.
    PubMed     Abstract available
    
    
    
30. YAMADA S, Morine Y, Ikemoto T, Saito Y, et al
    Inhibitory effect of non-alcoholic steatohepatitis on colon cancer liver metastasis.
    Eur J Surg Oncol. 2022 Nov 4. pii: S0748-7983(22)00718.
    PubMed     Abstract available
    
    
    
31. CASEY L, Larach JT, Waters PS, Kong JC, et al
    Application of minimally invasive approaches to pelvic exenteration for locally advanced and locally recurrent pelvic malignancy - A narrative review of outcomes in an evolving field.
    Eur J Surg Oncol. 2022;48:2330-2337.
    PubMed     Abstract available
    
    
    
32. WANG J, Prabhakaran S, Larach T, Warrier SK, et al
    Treatment strategies for locally recurrent rectal cancer.
    Eur J Surg Oncol. 2022;48:2292-2298.
    PubMed    
    
    
    
33. COLLINS D, Jones R, Griffiths B
    Anatomical approaches in locally advanced and recurrent pelvic malignancy.
    Eur J Surg Oncol. 2022;48:2258-2262.
    PubMed     Abstract available
    
    
    
34. FAHY MR, Hayes C, Kelly ME, Winter DC, et al
    Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer.
    Eur J Surg Oncol. 2022;48:2284-2291.
    PubMed     Abstract available
    
    
    
35. DRAMI I, Lord AC, Sarmah P, Baker RP, et al
    Preoperative assessment and optimisation for pelvic exenteration in locally advanced and recurrent rectal cancer: A review.
    Eur J Surg Oncol. 2022;48:2250-2257.
    PubMed     Abstract available
    
    
    
36. HAZEN SJA, Sluckin TC, Konishi T, Kusters M, et al
    Lateral lymph node dissection in rectal cancer: State of the art review.
    Eur J Surg Oncol. 2022;48:2315-2322.
    PubMed     Abstract available
    
    
    October 2022
37. BLIND N, Gunnarsson U, Strigard K, Brannstrom F, et al
    The impact of a patient's social network on emergency surgery for colon cancer.
    Eur J Surg Oncol. 2022 Oct 4. pii: S0748-7983(22)00689.
    PubMed     Abstract available
    
    
    
38. CHEN YH, Su YC, Hsu CW, Hsieh MC, et al
    Mortality of patients with metastatic colorectal cancer who received elective or emergent operation after exposure to bevacizumab: A nationwide database study.
    Eur J Surg Oncol. 2022 Oct 1. pii: S0748-7983(22)00688.
    PubMed     Abstract available
    
    
    
39. CHEN X, Huang Z, Zhang Y
    Letter to the editor: "The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group".
    Eur J Surg Oncol. 2022;48:2233-2234.
    PubMed    
    
    
    
40. GUERRA F
    Reply to: Letter to the Editor: "The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group".
    Eur J Surg Oncol. 2022;48:2235-2236.
    PubMed    
    
    
    
41. ZHANG Y, Chen Y, Huang J, Wu X, et al
    Mucinous histology is associated with poor prognosis in locally advanced colorectal adenocarcinoma treated with postoperative first-line adjuvant chemotherapy: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022;48:2075-2081.
    PubMed     Abstract available
    
    
    
42. FLOOD MP, Jain A, Mitchell C, Hewitt C, et al
    The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2022;48:2218-2225.
    PubMed     Abstract available
    
    
    
43. FRUHLING P, Urdzik J, Isaksson B
    Chemotherapy in patients with a solitary colorectal liver metastasis - A nationwide propensity score matched study.
    Eur J Surg Oncol. 2022;48:2188-2194.
    PubMed     Abstract available
    
    
    September 2022
44. DOLIN TG, Christensen IJ, Lund CM, Bojesen SE, et al
    Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival.
    Eur J Surg Oncol. 2022 Sep 11. pii: S0748-7983(22)00651.
    PubMed     Abstract available
    
    
    August 2022
45. VAN LEEUWEN B
    Editorial in response to "Peritoneal metastases in elderly patients with colorectal cancer".
    Eur J Surg Oncol. 2022 Aug 23. pii: S0748-7983(22)00622.
    PubMed    
    
    
    
46. ZOU M, Yang ZQ, Gao F
    Letter to the editor "Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death".
    Eur J Surg Oncol. 2022 Aug 19. pii: S0748-7983(22)00599.
    PubMed    
    
    
    
47. ROMANO G, Di Buono G, Galia M, Agnello F, et al
    Role of preoperative CT angiography with multimodality imaging reconstruction to perform laparoscopic Complete Mesocolic Excision (CME) and Central Vascular Ligation (CVL) in right-sided colon cancer: Is it really useful? A prospective clinical study.
    Eur J Surg Oncol. 2022 Aug 17. pii: S0748-7983(22)00596.
    PubMed     Abstract available
    
    
    
48. ZAMARAY B, van Velzen RA, Snaebjornsson P, Consten ECJ, et al
    Outcomes of patients with perforated colon cancer: A systematic review.
    Eur J Surg Oncol. 2022 Aug 15. pii: S0748-7983(22)00597.
    PubMed     Abstract available
    
    
    
49. HASSAN S, Malcomson L, Soh YJ, Wilson MS, et al
    Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.
    Eur J Surg Oncol. 2022 Aug 4. pii: S0748-7983(22)00561.
    PubMed     Abstract available
    
    
    
50. KORNER H, Guren MG, Larsen IK, Haugen DF, et al
    Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients.
    Eur J Surg Oncol. 2022;48:1831-1839.
    PubMed     Abstract available
    
    
    July 2022
51. KROON HM, Hoogervorst LA, Hanna-Rivero N, Traeger L, et al
    Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
    Eur J Surg Oncol. 2022;48:1475-1482.
    PubMed     Abstract available
    
    
    
52. STROMBERG C, Martinez de la Maza L, Fernandez Moro C, Gerling M, et al
    Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:1656-1663.
    PubMed     Abstract available
    
    
    
53. SUZUKI C, Halperin SK, Nilsson PJ, Martling A, et al
    Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
    Eur J Surg Oncol. 2022;48:1643-1649.
    PubMed     Abstract available
    
    
    
54. FUKUI Y, Hida K, Hoshino N, Song SH, et al
    Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study.
    Eur J Surg Oncol. 2022;48:1631-1637.
    PubMed     Abstract available
    
    
    June 2022
55. BHIMANI N, Wong GY, Molloy C, Dieng M, et al
    Cost of colorectal cancer by treatment type from different health economic perspectives: A systematic review.
    Eur J Surg Oncol. 2022 Jun 23. pii: S0748-7983(22)00528.
    PubMed     Abstract available
    
    
    
56. ZWANENBURG ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, et al
    Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion.
    Eur J Surg Oncol. 2022 Jun 11. pii: S0748-7983(22)00478.
    PubMed     Abstract available
    
    
    
57. BIRGIN E, Doyon F, Burkert J, Teoule P, et al
    Prognostic value of disease-free interval in colorectal cancer: Is it time?
    Eur J Surg Oncol. 2022 Jun 3. pii: S0748-7983(22)00485.
    PubMed     Abstract available
    
    
    
58. MOHAMED A, Nicolais L, Fitzgerald TL
    Predicting loss of independence after high-risk gastrointestinal abdominal surgery: Frailty vs. NSQIP risk calculator.
    Eur J Surg Oncol. 2022;48:1433-1438.
    PubMed     Abstract available
    
    
    
59. VAN GESTEL T, Groen LCB, Puik JR, van Rooijen SJ, et al
    Fit4Surgery for cancer patients during covid-19 lockdown - A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022;48:1189-1197.
    PubMed     Abstract available
    
    
    
60. VAN DE GEEST TW, van Amerongen MJ, Nierop PMH, Hoppener DJ, et al
    Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:1368-1374.
    PubMed     Abstract available
    
    
    
61. DI MARTINO M, Dorcaratto D, Primavesi F, Syn N, et al
    Liver resection in elderly patients with extensive CRLM: Are we offering an adequate treatment? A propensity score matched analysis.
    Eur J Surg Oncol. 2022;48:1331-1338.
    PubMed     Abstract available
    
    
    
62. KETELAERS SHJ, Orsini RG, Nieuwenhuijzen GAP, Rutten HJT, et al
    Outcomes on diverting ostomy formation and reversal after low anterior resection in the older more advanced rectal cancer patient.
    Eur J Surg Oncol. 2022;48:1414-1420.
    PubMed     Abstract available
    
    
    May 2022
63. STURESSON C, Engstrand J, Stromberg C
    Reply to: The cohort data in the full pulmonary Metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 May 27. pii: S0748-7983(22)00471.
    PubMed    
    
    
    
64. FEENSTRA TM, Verberne CJ, Kok NF, Aalbers AGJ, et al
    Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer.
    Eur J Surg Oncol. 2022 May 22. pii: S0748-7983(22)00463.
    PubMed     Abstract available
    
    
    
65. SCHUURMAN MS, Elferink MAG, Verhoef C, de Hingh IHJT, et al
    Peritoneal metastases in elderly patients with colorectal cancer.
    Eur J Surg Oncol. 2022 May 18. pii: S0748-7983(22)00438.
    PubMed     Abstract available
    
    
    
66. AGRAWAL A, Kazi M, Gori J, Dev I, et al
    Prospective study to assess the role of FDG PET/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes.
    Eur J Surg Oncol. 2022;48:1093-1099.
    PubMed     Abstract available
    
    
    
67. ABD EL AZIZ MA, McKenna NP, Jakub JW, Hallemeier CL, et al
    Rectal cancer with synchronous inguinal lymph node metastasis without distant metastasis. A call for further oncological evaluation.
    Eur J Surg Oncol. 2022;48:1100-1103.
    PubMed     Abstract available
    
    
    
68. SUKUMAR V, Kazi M, Gori J, Ankathi SK, et al
    Learning curve analysis for lateral pelvic lymph node dissection in rectal cancers - Outcomes improve with experience.
    Eur J Surg Oncol. 2022;48:1110-1116.
    PubMed     Abstract available
    
    
    
69. GIESEN LJX, Olthof PB, Elferink MAG, van Westreenen HL, et al
    Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort.
    Eur J Surg Oncol. 2022;48:1117-1122.
    PubMed     Abstract available
    
    
    
70. VERSEVELD M, Verver D, Noordman BJ, Pouwels S, et al
    Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice.
    Eur J Surg Oncol. 2022;48:1153-1160.
    PubMed     Abstract available
    
    
    
71. LIM WH, Tan DJH, Ng CH, Syn N, et al
    Laparoscopic versus open resection for rectal cancer: An individual patient data meta analysis of randomized controlled trials.
    Eur J Surg Oncol. 2022;48:1133-1143.
    PubMed     Abstract available
    
    
    
72. ASSI H, Persson A, Palmquist I, Oberg M, et al
    Short-term outcomes following beyond total mesorectal excision and reconstruction using myocutaneous flaps: A retrospective cohort study.
    Eur J Surg Oncol. 2022;48:1161-1166.
    PubMed     Abstract available
    
    
    April 2022
73. STRUYS M, Ceelen W
    Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00414.
    PubMed     Abstract available
    
    
    
74. CUIJPERS ACM, Linskens FG, Bongers BC, Stassen LPS, et al
    Quality and clinical generalizability of feasibility outcomes in exercise prehabilitation before colorectal cancer surgery - A systematic review.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00406.
    PubMed     Abstract available
    
    
    
75. TREASURE T, Williams NR, Macbeth F
    The cohort data in the full pulmonary metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00408.
    PubMed    
    
    
    
76. PEDRAZZANI C, Kim HJ, Park EJ, Turri G, et al
    Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort.
    Eur J Surg Oncol. 2022 Apr 22. pii: S0748-7983(22)00409.
    PubMed     Abstract available
    
    
    
77. CHAN AK, Ignatowicz AM, Mason JM, Siriwardena AK, et al
    Colorectal cancer and synchronous liver metastases: An individual case-based qualitative study (CoSMIC-Q).
    Eur J Surg Oncol. 2022 Apr 14. pii: S0748-7983(22)00385.
    PubMed     Abstract available
    
    
    
78. BOOME IT, Somers AMJ, Graupner C, Kimman ML, et al
    Development and content validation of the Assessment of Burden of ColoRectal Cancer (ABCRC)-tool.
    Eur J Surg Oncol. 2022 Apr 7. pii: S0748-7983(22)00379.
    PubMed     Abstract available
    
    
    
79. NORS J, Iversen LH, Nielsen K, Sorensen MM, et al
    Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:795-802.
    PubMed     Abstract available
    
    
    
80. O'CONNELL E, McDevitt J, Hill ADK, McNamara DA, et al
    Centralisation of rectal cancer care has improved patient survival in the republic of Ireland.
    Eur J Surg Oncol. 2022;48:890-895.
    PubMed     Abstract available
    
    
    
81. HORIE K, Matsuda T, Yamashita K, Hasegawa H, et al
    Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
    Eur J Surg Oncol. 2022;48:850-856.
    PubMed     Abstract available
    
    
    
82. CHEN Q, Chen J, Huang Z, Zhao H, et al
    Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Eur J Surg Oncol. 2022;48:864-872.
    PubMed     Abstract available
    
    
    
83. FOPPA C, Tamburello S, Maroli A, Carvello M, et al
    Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
    Eur J Surg Oncol. 2022;48:857-863.
    PubMed     Abstract available
    
    
    
84. KRUL MF, Gerritsen SL, Vissers FL, Klompenhouwer EG, et al
    Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:834-840.
    PubMed     Abstract available
    
    
    March 2022
85. PRING ET, Malietzis G, Gould LE, Lung P, et al
    Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00134.
    PubMed     Abstract available
    
    
    
86. ENGSTRAND J, Sterner J, Hasselgren K, Stromberg C, et al
    Treatment intention and outcome in patients with simultaneously diagnosed liver and lung metastases from colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 11. pii: S0748-7983(22)00128.
    PubMed     Abstract available
    
    
    
87. MADONIA D, Graf W, Ghanipour L
    The incidence and prognostic importance of ovarian involvement in patients with peritoneal metastasis undergoing CRS-HIPEC.
    Eur J Surg Oncol. 2022;48:666-671.
    PubMed     Abstract available
    
    
    
88. BAJRIC T, Kornprat P, Faschinger F, Werkgartner G, et al
    Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:615-620.
    PubMed     Abstract available
    
    
    February 2022
89. MC ENTEE PD, Shokuhi P, Rogers AC, Mehigan BJ, et al
    Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death.
    Eur J Surg Oncol. 2022 Feb 19. pii: S0748-7983(22)00090.
    PubMed     Abstract available
    
    
    
90. SARJANOJA E, Klintrup K, Ohtonen P, Kauppila JH, et al
    Annual hospital volume and colorectal cancer survival in a population-based nationwide cohort study in Finland.
    Eur J Surg Oncol. 2022 Feb 18. pii: S0748-7983(22)00111.
    PubMed     Abstract available
    
    
    
91. SUGARBAKER PH, Chang D
    Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators.
    Eur J Surg Oncol. 2022 Feb 3. pii: S0748-7983(22)00074.
    PubMed     Abstract available
    
    
    
92. UEDA K, Yamada T, Ohta R, Matsuda A, et al
    BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy.
    Eur J Surg Oncol. 2022 Feb 2. pii: S0748-7983(22)00042.
    PubMed     Abstract available
    
    
    
93. ELFRINK AKE, Kok NFM, Swijnenburg RJ, den Dulk M, et al
    Nationwide oncological networks for resection of colorectal liver metastases in the Netherlands: Differences and postoperative outcomes.
    Eur J Surg Oncol. 2022;48:435-448.
    PubMed     Abstract available
    
    
    
94. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    PubMed     Abstract available
    
    
    
95. VAN 'T SANT I, Nerad E, Rijsemus CJV, Engbersen MP, et al
    Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.
    Eur J Surg Oncol. 2022;48:462-469.
    PubMed     Abstract available
    
    
    January 2022
96. CHO HJ, Lee IK, Lee YS, Yun SS, et al
    Application of venous thromboembolism prophylaxis program in patients with colorectal cancer using the enhanced recovery after surgery protocol.
    Eur J Surg Oncol. 2022 Jan 31. pii: S0748-7983(22)00048.
    PubMed     Abstract available
    
    
    
97. SUGARBAKER PH, Chang D
    Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases.
    Eur J Surg Oncol. 2022 Jan 13. pii: S0748-7983(22)00011.
    PubMed     Abstract available
    
    
    
98. VAN DORP M, Bousema JE, Torensma B, Dickhoff C, et al
    Pulmonary metastasectomy with lymphadenectomy for colorectal pulmonary metastases: A systematic review.
    Eur J Surg Oncol. 2022;48:253-260.
    PubMed     Abstract available
    
    
    
99. NG L, Li X, Wan TM, Iyer D, et al
    Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
    Eur J Surg Oncol. 2022;48:245-252.
    PubMed     Abstract available
    
    
    
100. BOGVERADZE N, Lambregts DMJ, El Khababi N, Dresen RC, et al
     The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: Reproducibility, pitfalls and potential impact on treatment stratification.
     Eur J Surg Oncol. 2022;48:237-244.
     PubMed     Abstract available
     
     
     
101. MORAIS M, Pinto DM, Machado JC, Carneiro S, et al
     ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.
     Eur J Surg Oncol. 2022;48:218-227.
     PubMed     Abstract available
     
     
     
102. ASSAF D, Mor E, Laks S, Zohar N, et al
     The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
     Eur J Surg Oncol. 2022;48:197-203.
     PubMed     Abstract available
     
     
     
103. MA SM, Dong J, Liang L, Liu XT, et al
     The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis.
     Eur J Surg Oncol. 2022;48:211-217.
     PubMed     Abstract available
     
     
     
104. VERWAAL VJ, Funder JA, Sorensen MM, Iversen LH, et al
     The impact of postoperative complications following cytoreductive surgery combined with oxaliplatin based heated intraperitoneal chemotherapy.
     Eur J Surg Oncol. 2022;48:183-187.
     PubMed     Abstract available
     
     
     
105. VILLAMONTE M, Burdio F, Pueyo E, Andaluz A, et al
     The impact of additional margin coagulation with radiofrequency in liver resections with subcentimetric margin: can we improve the oncological results? A propensity score matching study.
     Eur J Surg Oncol. 2022;48:82-88.
     PubMed     Abstract available
     
     
     December 2021
106. DUMONT F, Guenole S, Loaec C, Bourgin C, et al
     Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
     Eur J Surg Oncol. 2021 Dec 22. pii: S0748-7983(21)00995.
     PubMed     Abstract available
     
     
     
107. MEYER Y, Olthof PB, Grunhagen DJ, de Hingh I, et al
     Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study.
     Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00951.
     PubMed     Abstract available
     
     
     
108. PIOZZI GN, Rusli SM, Baek SJ, Kwak JM, et al
     Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: A systematic review.
     Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00952.
     PubMed     Abstract available
     
     
     
109. BOSMA NA, Keehn AR, Lee-Ying R, Karim S, et al
     Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2021;47:3113-3122.
     PubMed     Abstract available
     
     
     
110. SPINELLI A, Foppa C, Carvello M, Sacchi M, et al
     Transanal Transection and Single-Stapled Anastomosis (TTSS): A comparison of anastomotic leak rates with the double-stapled technique and with transanal total mesorectal excision (TaTME) for rectal cancer.
     Eur J Surg Oncol. 2021;47:3123-3129.
     PubMed     Abstract available
     
     
     
111. WANG Z, Liu Z, Wen Z, Li R, et al
     Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
     Eur J Surg Oncol. 2021;47:3166-3174.
     PubMed     Abstract available
     
     
     
112. AKIYOSHI T, Yamaguchi T, Hiratsuka M, Mukai T, et al
     Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
     Eur J Surg Oncol. 2021;47:3157-3165.
     PubMed     Abstract available
     
     
     
113. ZHENG Z, Wang X, Liu Z, Lu X, et al
     Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.
     Eur J Surg Oncol. 2021;47:3175-3181.
     PubMed     Abstract available
     
     
     November 2021
114. BENAVIDES M, Gomez-Espana A, Garcia-Alfonso P, Gonzalez CG, et al
     Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
     Eur J Surg Oncol. 2021 Nov 25. pii: S0748-7983(21)00931.
     PubMed     Abstract available
     
     
     
115. WARPS AK, Tollenaar RAEM, Tanis PJ, Dekker JWT, et al
     Postoperative complications after colorectal cancer surgery and the association with long-term survival.
     Eur J Surg Oncol. 2021 Nov 11. pii: S0748-7983(21)00785.
     PubMed     Abstract available
     
     
     
116. DE NES LCF, van der Heijden JAG, Verstegen MG, Drager L, et al
     Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer.
     Eur J Surg Oncol. 2021 Nov 6. pii: S0748-7983(21)00789.
     PubMed     Abstract available
     
     
     
117. WARPS AK, Detering R, Tollenaar RAEM, Tanis PJ, et al
     Textbook outcome after rectal cancer surgery as a composite measure for quality of care: A population-based study.
     Eur J Surg Oncol. 2021;47:2821-2829.
     PubMed     Abstract available
     
     
     
118. GUERRA F, Petrelli F, Greco PA, Sisti V, et al
     The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group.
     Eur J Surg Oncol. 2021;47:2873-2879.
     PubMed     Abstract available
     
     
     
119. LJUNGGREN M, Nordenvall C, Palmer G
     Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
     Eur J Surg Oncol. 2021;47:2865-2872.
     PubMed     Abstract available
     
     
     
120. GAU L, Ribeiro M, Pereira B, Poirot K, et al
     Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis.
     Eur J Surg Oncol. 2021;47:2722-2733.
     PubMed     Abstract available
     
     
     
121. BAE HW, Kim HS, Yang SY, Kim HS, et al
     Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
     Eur J Surg Oncol. 2021;47:2814-2820.
     PubMed     Abstract available
     
     
     
122. VAN DE VLASAKKER VCJ, Lurvink RJ, Cashin PH, Ceelen W, et al
     The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
     Eur J Surg Oncol. 2021;47:2888-2892.
     PubMed     Abstract available
     
     
     October 2021
123. DI GIORGIO A, Rotolo S, Cintoni M, Rinninella E, et al
     The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00763.
     PubMed     Abstract available
     
     
     
124. HODGES N, Mackenzie H, D'Souza N, Brown G, et al
     Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
     Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00760.
     PubMed     Abstract available
     
     
     
125. GALEMA HA, Meijer RPJ, Lauwerends LJ, Verhoef C, et al
     Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives.
     Eur J Surg Oncol. 2021 Oct 9. pii: S0748-7983(21)00755.
     PubMed     Abstract available
     
     
     
126. KATAOKA K, Yamada T, Taniguchi H, Ikeda M, et al
     A ctDNA-driven multidisciplinary treatment strategy for resectable colorectal cancer -what surgical oncologists should know.
     Eur J Surg Oncol. 2021 Oct 7. pii: S0748-7983(21)00752.
     PubMed    
     
     
     
127. FIORICA F, Napoli G, Berretta M, Soliani G, et al
     Letter to editor: A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
     Eur J Surg Oncol. 2021;47:2700-2701.
     PubMed    
     
     
     
128. YUKSEL BC
     Comment on 'Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients'.
     Eur J Surg Oncol. 2021;47:2696.
     PubMed    
     
     
     
129. CLANCY C, Martin ST
     Reply to: Commentary to "A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours".
     Eur J Surg Oncol. 2021;47:2702-2703.
     PubMed    
     
     
     
130. GIGLIO MC, Garofalo E, Montalti R, Vanlander A, et al
     The learning curve of laparoscopic ablation of liver tumors: A technically demanding procedure requiring dedicated training.
     Eur J Surg Oncol. 2021;47:2579-2585.
     PubMed     Abstract available
     
     
     September 2021
131. KROON HM, Kusters M, Chang GJ, Sammour T, et al
     Reply to: Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
     Eur J Surg Oncol. 2021;47:2477-2478.
     PubMed    
     
     
     
132. PATEL S, Kazi M, Saklani A
     Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
     Eur J Surg Oncol. 2021;47:2475-2476.
     PubMed    
     
     
     
133. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
     Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
     Eur J Surg Oncol. 2021;47:2473-2474.
     PubMed    
     
     
     
134. PATEL S, Prem A, Raghavan S
     Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
     Eur J Surg Oncol. 2021;47:2472.
     PubMed    
     
     
     
135. DAY N
     Reply to: CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
     Eur J Surg Oncol. 2021;47:2467.
     PubMed    
     
     
     
136. KROON HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, et al
     Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
     Eur J Surg Oncol. 2021;47:2441-2449.
     PubMed     Abstract available
     
     
     
137. MARIATHASAN AB, Boye K, Dueland S, Flatmark K, et al
     Metastases in locally advanced rectal cancer undergoing curatively intended treatment.
     Eur J Surg Oncol. 2021;47:2377-2383.
     PubMed     Abstract available
     
     
     
138. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
     Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
     Eur J Surg Oncol. 2021;47:2429-2435.
     PubMed     Abstract available
     
     
     
139. FAHIM M, Dijksman LM, Derksen WJM, Bloemen JG, et al
     Prospective multicentre study of a new bowel obstruction treatment in colorectal surgery: Reduced morbidity and mortality.
     Eur J Surg Oncol. 2021;47:2414-2420.
     PubMed     Abstract available
     
     
     
140. MORARASU S, O'Brien L, Clancy C, Dietrich D, et al
     A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
     Eur J Surg Oncol. 2021;47:2421-2428.
     PubMed     Abstract available
     
     
     
141. KAZI M, Saklani A
     CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
     Eur J Surg Oncol. 2021;47:2465-2466.
     PubMed    
     
     
     
142. GIESEN LJX, Olthof PB, Elferink MAG, Verhoef C, et al
     Surgery for rectal cancer: Differences in resection rates among hospitals in the Netherlands.
     Eur J Surg Oncol. 2021;47:2384-2389.
     PubMed     Abstract available
     
     
     
143. CALINI G, Abd El Aziz MA, Abdalla S, Saeed HA, et al
     Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors.
     Eur J Surg Oncol. 2021;47:2436-2440.
     PubMed     Abstract available
     
     
     August 2021
144. DASTER S, Shin JS, Loizides S, Steffens D, et al
     Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer.
     Eur J Surg Oncol. 2021;47:2100-2107.
     PubMed     Abstract available
     
     
     
145. DAY N, D'Souza N, Shaw A, Lord A, et al
     Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients.
     Eur J Surg Oncol. 2021;47:2093-2099.
     PubMed     Abstract available
     
     
     
146. LI K, He X, Tong S, Zheng Y, et al
     Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study.
     Eur J Surg Oncol. 2021;47:2087-2092.
     PubMed     Abstract available
     
     
     
147. WILSON K, Flood M, Narasimhan V, Pham T, et al
     Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review.
     Eur J Surg Oncol. 2021;47:1862-1874.
     PubMed     Abstract available
     
     
     
148. KLOSE J, Schmitt A, Pernthaler J, Warschkow R, et al
     Still proliferating CD44(+)/Ki67(+) tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival.
     Eur J Surg Oncol. 2021;47:2078-2086.
     PubMed     Abstract available
     
     
     
149. PIOZZI GN, Park H, Lee TH, Kim JS, et al
     Risk factors for local recurrence and long term survival after minimally invasive intersphincteric resection for very low rectal cancer: Multivariate analysis in 161 patients.
     Eur J Surg Oncol. 2021;47:2069-2077.
     PubMed     Abstract available
     
     
     
150. LANCELLOTTI F, Solinas L, Sagnotta A, Mancini S, et al
     Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
     Eur J Surg Oncol. 2021;47:2046-2052.
     PubMed     Abstract available
     
     
     
151. VILLARD C, Habib M, Nordenvall C, Nilsson PJ, et al
     Conversion therapy in patients with colorectal liver metastases.
     Eur J Surg Oncol. 2021;47:2038-2045.
     PubMed     Abstract available
     
     
     July 2021
152. KIM JC, Kim CW, Lee JL, Yoon YS, et al
     Complete intersphincteric longitudinal muscle excision May Be key to reducing local recurrence during intersphincteric resection.
     Eur J Surg Oncol. 2021;47:1629-1636.
     PubMed     Abstract available
     
     
     
153. DU R, Zhou J, Tong G, Chang Y, et al
     Postoperative morbidity and mortality after anterior resection with preventive diverting loop ileostomy versus loop colostomy for rectal cancer: A updated systematic review and meta-analysis.
     Eur J Surg Oncol. 2021;47:1514-1525.
     PubMed     Abstract available
     
     
     
154. DENOST Q, Assenat V, Vendrely V, Celerier B, et al
     Oncological strategy following R1 sphincter-saving resection in low rectal cancer after chemoradiotherapy.
     Eur J Surg Oncol. 2021;47:1683-1690.
     PubMed     Abstract available
     
     
     
155. WANG T, Zhao Y, Wang M, Zhang P, et al
     Radical resection versus local excision for low rectal gastrointestinal stromal tumor: A multicenter propensity score-matched analysis.
     Eur J Surg Oncol. 2021;47:1668-1674.
     PubMed     Abstract available
     
     
     
156. VAN REES JM, Hoppener DJ, Hagemans JAW, Rothbarth J, et al
     The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer.
     Eur J Surg Oncol. 2021;47:1616-1622.
     PubMed     Abstract available
     
     
     June 2021
157. KAECH M, Deutschmann E, Moffa G, Haak F, et al
     Influence of the introduction of caseload requirements on indication for visceral cancer surgery in Switzerland.
     Eur J Surg Oncol. 2021;47:1324-1331.
     PubMed     Abstract available
     
     
     
158. CLIFFORD RE, Gerrard AD, Fok M, Vimalachandran D, et al
     Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature.
     Eur J Surg Oncol. 2021;47:1252-1257.
     PubMed     Abstract available
     
     
     
159. ARJONA-SANCHEZ A, Aziz O, Passot G, Salti G, et al
     Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
     Eur J Surg Oncol. 2021;47:1420-1426.
     PubMed     Abstract available
     
     
     May 2021
160. YE J, Tian Y, Li F, van Oostendorp S, et al
     Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
     Eur J Surg Oncol. 2021;47:1019-1025.
     PubMed     Abstract available
     
     
     
161. MEILLAT H, Braticevic C, Zemmour C, Brun C, et al
     Real-world implementation of a geriatric-specific ERAS protocol in patients undergoing colonic cancer surgery.
     Eur J Surg Oncol. 2021;47:1012-1018.
     PubMed     Abstract available
     
     
     
162. OGURA A, Uehara K, Aiba T, Sando M, et al
     Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancer.
     Eur J Surg Oncol. 2021;47:1005-1011.
     PubMed     Abstract available
     
     
     
163. STERPETTI AV, Marzo LD, Sapienza P
     Risk factors for adenocarcinoma in the surgically transposed colon not exposed to the fecal stream. Etiological considerations extrapolated to sporadic colon carcinoma in the general population.
     Eur J Surg Oncol. 2021;47:931-934.
     PubMed     Abstract available
     
     
     
164. GAO TM, Bai DS, Qian JJ, Zhang C, et al
     Real-world clinical significance of nonbiological factors with staging, prognosis and clinical management in rectal cancer.
     Eur J Surg Oncol. 2021;47:990-998.
     PubMed     Abstract available
     
     
     April 2021
165. GILLIS C, Fenton TR, Gramlich L, Sajobi TT, et al
     Older frail prehabilitated patients who cannot attain a 400 m 6-min walking distance before colorectal surgery suffer more postoperative complications.
     Eur J Surg Oncol. 2021;47:874-881.
     PubMed     Abstract available
     
     
     
166. SCHULLIAN P, Johnston EW, Putzer D, Laimer G, et al
     Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
     Eur J Surg Oncol. 2021;47:866-873.
     PubMed     Abstract available
     
     
     
167. CONCI S, Ruzzenente A, Pedrazzani C, Isa G, et al
     Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes.
     Eur J Surg Oncol. 2021;47:842-849.
     PubMed     Abstract available
     
     
     
168. ASSI H, Persson A, Palmquist I, Oberg M, et al
     Sexual and functional long-term outcomes following advanced pelvic cancer and reconstruction using vertical rectus abdominis myocutaneous and gluteal myocutaneous flap.
     Eur J Surg Oncol. 2021;47:858-865.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: